DermaSensor
Developer of an AI-powered skin cancer detection device
📍 Miami, United States · Dermatology
Funding snapshot
Last roundSeries B
Amount$5M
Date10 June 2026
About
Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.
Latest news
No articles yet.